Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

The initial public offering market got back on its feet in 2024 and looks as if it will take some big steps forward in 2025. And that could happen sooner rather than later. According to Renaissance ...

Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and five SPACs also submitted initial filings. No traditional IPOs are currently scheduled for the week ahead as the government ...

Seven sizable IPOs debuted this week, the most in nearly four years, joined by 3 SPACs. Ten IPOs, mostly small issuers, submitted initial filings this week. Four sizable IPOs are currently scheduled ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...

When we introduced the Nasdaq IPO Pulse a year ago, we said it suggested that U.S. “IPO activity… should remain in an uptrend” as we headed into 2024. Then, when we introduced the Nasdaq Stockholm IPO ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...